Cargando…
Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
OBJECTIVE: To investigate the oxidized albumin ratio, which is the redox ratio of human nonmercaptalbumin (HNA) to serum albumin (%HNA), as a biomarker in idiopathic Parkinson’s disease (iPD) and related neurodegenerative disorders. METHODS: This prospective study enrolled 216 iPD patients, 15 patie...
Autores principales: | Ueno, Shin‐Ichi, Hatano, Taku, Okuzumi, Ayami, Saiki, Shinji, Oji, Yutaka, Mori, Akio, Koinuma, Takahiro, Fujimaki, Motoki, Takeshige‐Amano, Haruka, Kondo, Akihide, Yoshikawa, Naoyuki, Nojiri, Takahiro, Kurano, Makoto, Yasukawa, Keiko, Yatomi, Yutaka, Ikeda, Hitoshi, Hattori, Nobutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086006/ https://www.ncbi.nlm.nih.gov/pubmed/32059082 http://dx.doi.org/10.1002/acn3.50990 |
Ejemplares similares
-
Metabolomics‐based identification of metabolic alterations in PARK2
por: Okuzumi, Ayami, et al.
Publicado: (2019) -
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019) -
Evaluation of human nonmercaptalbumin as a marker for oxidative stress and its association with various parameters in blood
por: Masudo, Rie, et al.
Publicado: (2017) -
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
por: Saiki, Shinji, et al.
Publicado: (2017) -
Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease
por: Koinuma, Takahiro, et al.
Publicado: (2021)